Middle East Pharmaceutical Industries Co. announces the deposit of the amounts from selling the shares fractions resulted from the company’s capital Increase in the eligible shareholder’s accounts

Element List	Explanation
Introduction	Middle East Pharmaceutical Industries Company “Avalon Pharma” announces to its valued shareholders the completion of the sale of fractional shares resulting from the capital increase approved by the Extraordinary General Assembly, which included the increase of the company’s capital, held on Thursday, 11-05-2026G, corresponding to 24-11-1447H, and the deposit of the proceeds into the accounts of eligible shareholders.
Share’s Fractions Sale Completion Date	2026-05-17 Corresponding to 1447-11-30
Number of Sold Shares	56114
Share’s Fractions Selling Returned Amount	3,234,029.05
Average Selling Price per share	57.6331
Deposit Date of The Return Amount from Share’s Fractions Selling in Eligible Shareholder’s Accounts	2026-06-08 Corresponding to 1447-12-22
Name and Contact Method of Responsible Entity Distributing The Return Amount from Share’s Fractions Selling in Eligible Shareholder’s Accounts	The amounts resulting from the sale of fractional shares will be deposited through Banque Saudi Fransi (BSF). In the event of any delay in the deposit process, shareholders may visit the nearest BSF branch to receive their dues. For further inquiries, please contact the Investor Relations Department during official working hours from Sunday to Thursday, from 8:00 a.m. to 5:00 p.m. Phone: 0118365000, Extension (3374) Email: investor.relations@avalon.com.sa
Additional Information	None.